pyrazinamide has been researched along with calcitriol in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Crowle, AJ; May, MH | 1 |
Crowle, AJ; May, MH; Salfinger, M | 1 |
Chang, IT; Tsai, BL; Yang, WC | 1 |
Bao, R; Dai, M; Guo, M; Huang, ZX; Rao, Y; Wang, X; Yu, Q; Zhang, J | 1 |
1 review(s) available for pyrazinamide and calcitriol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for pyrazinamide and calcitriol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3.
Topics: Adult; Calcifediol; Calcitriol; Chloroquine; Culture Media; Female; Humans; In Vitro Techniques; Isoniazid; Macrophages; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Streptomycin | 1990 |
1,25(OH)2-vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macrophages.
Topics: Adult; Calcitriol; Cells, Cultured; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Synergism; Humans; Macrophages; Male; Mycobacterium tuberculosis; Pyrazinamide; Time Factors | 1989 |
Hypercalcemia in renal transplant patients with tuberculosis.
Topics: Adult; Antitubercular Agents; Blood Urea Nitrogen; Calcitriol; Calcium; Ethambutol; Humans; Hypercalcemia; Kidney Transplantation; Male; Parathyroid Hormone; Postoperative Complications; Pyrazinamide; Time Factors; Tuberculosis, Pulmonary | 2000 |
Calcitriol enhances pyrazinamide treatment of murine tuberculosis.
Topics: Animals; Antitubercular Agents; Calcitriol; Female; Mice; Mice, Inbred C57BL; Pyrazinamide; Tuberculosis | 2019 |